Ključne besede: SB2, CT-P13, multiple switches, Crohn's disease, inflammatory bowel disease, ulcerative colitis, adults, feces, c-reactive protein, infliximab, adverse event, leukocyte l1 antigen complex, infusion procedures, biosimilar pharmaceuticals, disease remission, imputation, antidrug antibody, infliximab-dyybCelotno besedilo (datoteka, 608,73 KB) Gradivo ima več datotek! Več...
Ključne besede: antibodies, enzyme-linked immunosorbent assay, infliximab, materials testingCelotno besedilo (datoteka, 286,74 KB) Gradivo ima več datotek! Več...